Selexipag for pulmonary arterial hypertension in a wide range of adult congenital heart disease

Alexandra C. van Dissel,Marco C. Post,GertJan T. Sieswerda,Hubert W. Vliegen,Arie P.J. van Dijk,Barbara J.M. Mulder,Berto J. Bouma

International Journal of Cardiology Congenital Heart Disease（2021）

引用 3|浏览0

暂无评分

摘要

•Tolerability for selexipag was low—particularly in patients with Eisenmenger syndrome.•Patient with PAH after defect correction have more clinical benefit from selexipag.•Selexipag improved risk status in patients with PAH after defect correction.

查看译文

关键词

Selexipag,Congenital heart disease,Pulmonary arterial hypertension

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要